ADP-ribosylarginine hydrolase Antibody - Azide and BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-20168
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Format
Azide and BSA Free
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Produced in rabbits immunized with purified, recombinant Human ADP-ribosylarginine hydrolase (Accession#: NP_001116.1; Met1-Leu351).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
This antibody can be stored at 2C-8C for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20C to -80C.
Applications for ADP-ribosylarginine hydrolase Antibody - Azide and BSA Free
Application
Recommended Usage
ELISA
1:5000-1:10000
Formulation, Preparation, and Storage
Purification
Antigen and protein A Affinity-purified
Formulation
0.2 um filtered solution in PBS
Format
Azide and BSA Free
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: ADP-ribosylarginine hydrolase
Alternate Names
[Protein ADP-ribosylarginine] hydrolase, ADP-ribosylarginine hydrolaseARH1ADP-ribose-L-arginine cleaving enzyme, EC 3.2.2.19
Gene Symbol
ADPRH
Additional ADP-ribosylarginine hydrolase Products
Product Documents for ADP-ribosylarginine hydrolase Antibody - Azide and BSA Free
Product Specific Notices for ADP-ribosylarginine hydrolase Antibody - Azide and BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...